metaMe Health has received FDA 510(k) clearance for Regulora, a prescription digital therapeutic aimed at treating abdominal pain associated with irritable bowel syndrome in adults.
Regulora is a smartphone app that delivers behavioral therapy based on gut-directed hypnotherapy to alleviate IBS pain.
“The FDA’s clearance of Regulora, our first PDT, is a major achievement for the company,” Tim...
The FDA has granted De Novo clearance to a prescription nerve stimulation device for the reduction of functional abdominal pain. The device is intended for use by adolescents and teens with irritable bowel syndrome in combination with other therapies.
Developed by Innovative Health Solutions, the IB-Stim devices is a single-use electrical nerve stimulator. When placed behind the patient’s ear, it...
Cara, a Berlin-based startup building a medical app for digestive health (a space the company has boldly dubbed “poop tech”), has raised a $2 million seed round. Atlantic Labs led the round, and additional investments came from angel investors. The company does business as Cara, the name of its app, but is officially known as HiDoc.
“Digestive issues are still a taboo topic but we are now making...
Salix Pharmaceuticals, a New Jersey-based drug development company that focuses on gastrointestinal conditions, wants to get the bottom of what causes irritable bowel syndrome (IBS). To study the common condition– which affects some 25 to 45 million Americans – Salix has developed an interactive, virtual reality platform designed to give clinicians a gut feeling for what could be causing IBS. ...
Litmus Health, a company helping pharma companies use wearable devices to improve the efficiency of Phase I and II drug trials, is coming out of public beta and announcing a trial with the University of Chicago testing the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients. The trial is funded via a grant from Takeda Pharmaeuticals.
"I see so many patients filling...
